131 related articles for article (PubMed ID: 16445900)
1. The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis.
Joven J; Coll B; Tous M; Ferré N; Alonso-Villaverde C; Parra S; Camps J
Clin Chim Acta; 2006 Jun; 368(1-2):114-9. PubMed ID: 16445900
[TBL] [Abstract][Full Text] [Related]
2. HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1.
Coll B; Parra S; Alonso-Villaverde C; de Groot E; Aragonés G; Montero M; Tous M; Camps J; Joven J; Masana L
Cytokine; 2006 Apr; 34(1-2):51-5. PubMed ID: 16697654
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele.
Alonso-Villaverde C; Coll B; Parra S; Montero M; Calvo N; Tous M; Joven J; Masana L
Circulation; 2004 Oct; 110(15):2204-9. PubMed ID: 15466648
[TBL] [Abstract][Full Text] [Related]
4. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
McDermott DH; Yang Q; Kathiresan S; Cupples LA; Massaro JM; Keaney JF; Larson MG; Vasan RS; Hirschhorn JN; O'Donnell CJ; Murphy PM; Benjamin EJ
Circulation; 2005 Aug; 112(8):1113-20. PubMed ID: 16116069
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia.
Tucci M; Quatraro C; Frassanito MA; Silvestris F
J Hypertens; 2006 Jul; 24(7):1307-18. PubMed ID: 16794480
[TBL] [Abstract][Full Text] [Related]
6. Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy.
Coll B; Alonso-Villaverde C; Parra S; Rabassa A; Martorell L; Joven J; Masana L
HIV Med; 2006 Sep; 7(6):356-60. PubMed ID: 16903979
[TBL] [Abstract][Full Text] [Related]
7. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
8. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
Gilbert J; Lekstrom-Himes J; Donaldson D; Lee Y; Hu M; Xu J; Wyant T; Davidson M;
Am J Cardiol; 2011 Mar; 107(6):906-11. PubMed ID: 21247529
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
[TBL] [Abstract][Full Text] [Related]
11. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
12. The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid.
Letendre S; Marquie-Beck J; Singh KK; de Almeida S; Zimmerman J; Spector SA; Grant I; Ellis R;
J Neuroimmunol; 2004 Dec; 157(1-2):193-6. PubMed ID: 15579297
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
14. Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients.
Jemaa R; Rojbani H; Kallel A; Ben Ali S; Feki M; Chabrak S; Elasmi M; Taieb SH; Sanhaji H; Souheil O; Mechmeche R; Kaabachi N
Clin Chim Acta; 2008 Apr; 390(1-2):122-5. PubMed ID: 18230355
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?
Coll B; Alonso-Villaverde C; Joven J
Clin Chim Acta; 2007 Aug; 383(1-2):21-9. PubMed ID: 17521622
[TBL] [Abstract][Full Text] [Related]
16. CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosis.
Alagarasu K; Selvaraj P; Swaminathan S; Raghavan S; Narendran G; Narayanan PR
Indian J Med Res; 2009 Oct; 130(4):444-50. PubMed ID: 19942750
[TBL] [Abstract][Full Text] [Related]
17. Host-pathogen interactions in the development of metabolic disturbances and atherosclerosis in HIV infection: the role of CCL2 genetic variants.
Alonso-Villaverde C; Aragonès G; Beltrán-Debón R; Fernández-Sender L; Rull A; Rodríguez-Sanabria F; Marsillach J; Pardo-Reche P; Camps J; Joven J
Cytokine; 2010 Sep; 51(3):251-8. PubMed ID: 20573518
[TBL] [Abstract][Full Text] [Related]
18. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A
Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891
[TBL] [Abstract][Full Text] [Related]
20. Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Kaur S; Panicker SR; James T; Sarma PS; Thankappan KR; Kartha CC
Metab Syndr Relat Disord; 2009 Jun; 7(3):193-8. PubMed ID: 19450143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
